GSK Third-Quarter Shingrix Sales Fall 5% to GBP780M
GSK reported Shingrix sales of GBP780 million in the third quarter, down 5% at constant currency.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
GSK reported Shingrix sales of GBP780 million in the third quarter, down 5% at constant currency.